Invasive Streptococcus pneumoniae disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The clones expressing IGHV1-69 and IGHV 3-21 provided significant passive protection against invasive pneumococcal disease in vivo.
|
17983446 |
2008 |
Chronic Lymphocytic Leukemia
|
0.600 |
Biomarker
|
disease |
CTD_human |
Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.
|
15817677 |
2005 |
Chronic Lymphocytic Leukemia
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
The first one (7 of 16 cases) carried a similar HCDR3 amino acid sequence (common-HCDR3 subset), virtually identical to the Scandinavian IGHV3-21 CLL.
|
15466924 |
2005 |
Chronic Lymphocytic Leukemia
|
0.600 |
Biomarker
|
disease |
ORPHANET |
To investigate the IGHV3-21 frequency and the clinical impact of IGHV3-21 stereotypy, 337 newly diagnosed Swedish CLL patients from a population-based cohort were analyzed.
|
22464020 |
2012 |
Chronic Lymphocytic Leukemia
|
0.600 |
Biomarker
|
disease |
ORPHANET |
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
|
21372840 |
2011 |
Chronic Lymphocytic Leukemia
|
0.600 |
Biomarker
|
disease |
ORPHANET |
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
|
22875913 |
2012 |
Chronic Lymphocytic Leukemia
|
0.600 |
Biomarker
|
disease |
ORPHANET |
Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome.
|
23637131 |
2013 |
B-CELL MALIGNANCY, LOW-GRADE
|
0.310 |
Biomarker
|
disease |
ORPHANET |
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
|
21372840 |
2011 |
B-CELL MALIGNANCY, LOW-GRADE
|
0.310 |
Biomarker
|
disease |
ORPHANET |
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
|
23637131 |
2013 |
B-CELL MALIGNANCY, LOW-GRADE
|
0.310 |
Biomarker
|
disease |
ORPHANET |
IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia.
|
22464020 |
2012 |
B-CELL MALIGNANCY, LOW-GRADE
|
0.310 |
Biomarker
|
disease |
ORPHANET |
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
|
22875913 |
2012 |
Small Lymphocytic Lymphoma
|
0.300 |
Biomarker
|
disease |
ORPHANET |
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
|
21372840 |
2011 |
Small Lymphocytic Lymphoma
|
0.300 |
Biomarker
|
disease |
ORPHANET |
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
|
22875913 |
2012 |
Small Lymphocytic Lymphoma
|
0.300 |
Biomarker
|
disease |
ORPHANET |
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
|
23637131 |
2013 |
Small Lymphocytic Lymphoma
|
0.300 |
Biomarker
|
disease |
ORPHANET |
IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia.
|
22464020 |
2012 |